# Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes

> **NCT00786136** · PHASE4 · COMPLETED · sponsor: **Shenyang Northern Hospital** · enrollment: 2998 (actual)

## Conditions studied

- Diabetes Mellitus
- Chronic Kidney Disease

## Interventions

- **DRUG:** rosuvastatin

## Key facts

- **NCT ID:** NCT00786136
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 2998 (ACTUAL)
- **Last updated:** 2013-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00786136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00786136, "Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00786136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*